Previous 10 | Next 10 |
Strong cross-currents increase risk of a correction. The best sectors are industrials, financials, and consumer goods. The top stocks to buy in every sector. For further details see: The Grinch Could Derail The Santa Claus Rally This Year
In a diversion from a positive advisory committee vote, the FDA has issued a Complete Response Letter ((CRL)) to Alkermes’s (ALKS) marketing application seeking approval for ALKS-3831 for the treatment of schizophrenia and with bipolar I disorder in adults...
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review -- No Clinical Efficacy or Safety Issues Raised and No Further Studies Required by FDA to Support Approval -- -- Company Plans to Engage With FDA Toward Expeditious Resolution of...
Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting - Subcutaneous Dosing of ALKS 4230 in ARTISTRY-2 Showed Desired Immune Response and Safety Profile Consistent With the Observed Effects of Intravenous ALKS 423...
Alkermes plc (ALKS) Q3 2020 Earnings Conference Call October 29, 2020 10:30 AM ET Company Participants Sandy Coombs - Vice President, Investor Relations Richard Pops - Chief Executive Officer Jim Frates - Chief Financial Officer Todd Nichols - Chief Commercial Officer Conference Call Particip...
Image source: The Motley Fool. Alkermes PLC (NASDAQ: ALKS) Q3 2020 Earnings Call Oct 30, 2020 , 8:00 p.m. ET Operator Continue reading For further details see: Alkermes PLC (ALKS) Q3 2020 Earnings Call Transcript
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET PR Newswire DUBLIN, Oct. 29, 2020 DUBLIN , Oct. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announces that the conference call to discuss the company's thi...
The following slide deck was published by Alkermes plc in conjunction with their 2020 Q3 earnings call. For further details see: Alkermes plc 2020 Q3 - Results - Earnings Call Presentation
Alkermes (ALKS): Q3 Non-GAAP EPS of $0.26 beats by $0.26; GAAP EPS of $0.00 beats by $0.29.Revenue of $265.01M (+3.8% Y/Y) beats by $26.62M.Shares +0.91% PM.Press Release For further details see: Alkermes EPS beats by $0.26, beats on revenue
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations - Company Reports Third Quarter Revenues of $265.0 Million, GAAP Net Loss per Share of $0.00 and Basic and Diluted Non-GAAP Earnings per Share of $0.26 - - ARISTADA® Net Sal...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...